HALONasdaq United States
Market cap
$12.231 B
$103.12 +20.24%
Close of 7 Aug 2026
Revenue
$1.40B
#1342 by revenue
Earnings
$316.9M
#814 by earnings
Shares outstanding
113,498,000
Latest filing cover page
P/E ratio
38.6
Cap ÷ net income
Where these numbers come from
Share counts and financials for Halozyme Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.